Citizens Financial Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-110,953
Closed -$161K – 1073
2026
Q1
$161K Buy
+110,953
New +$176K ﹤0.01% 813
2025
Q2
– Sell
-83,000
Closed -$305K – 712
2025
Q1
$305K Buy
+83,000
New +$303K 0.01% 502
2020
Q3
– Sell
-100
Closed – – 841
2020
Q2
$0 Buy
+100
New +$205 ﹤0.01% 1181

Other funds holding STIM

Citizens Financial Group's STIM Position: Q2 2026 in Review

Citizens Financial Group sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 110,953 shares — an estimated $161K sold.

Citizens Financial Group first reported a position in STIM in Q2 2020 and held it in 3 quarters. The position peaked at $305K in Q1 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Citizens Financial Group reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Citizens Financial Group sold 110,953 Neuronetics shares in Q2 2026, an estimated $161K.
  • Citizens Financial Group first reported a position in Neuronetics in Q2 2020 and held it in 3 quarters.
  • Citizens Financial Group's Neuronetics position peaked at $305K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.